with analytics processing real time data to network and integrate disparate EMR systems from multiple facilities; iQ EHR Auditing, a technology that applies advanced analytics and text mining to uncover inconsistencies in EHR and claims data; iQ ACO Software, which enables accountable care organizations (ACO) to achieve an analytical view of entire networks and individual patients; iQ EHR Data Mining, which are predictive modeling modules for quality benchmarking, risk profiling, disease management, and other applications; and iQ EHR Reporting, which enables system-wide assessment of use and financial impact of non-compliance. The company’s products include EHR Data Auditor, an EHR analytics platform used for behavior modeling of patient groups to identify an under-reporting of HIV+ patients; Diabetes Management Scorecard, a technology used to assess diabetes management across a network of disparate EMRs; COPD Population Profiler, a technology focused on chronic disease management, and to predict and manage COPD patients; Readmission Predictor, a platform based on EMR integration framework to provide a predictive modeling plug-and-play module for predicting patients at risk for hospital re-admission; Predictive Claims Auditor, an EMR integration framework to detect and prevent erroneous clinical data entries; Predictive Patient Outreach, which is used to predict optimal targets and channels for marketing initiatives; and Clinician Profiler, an integrated system for profiling clinicians, calculating practice variations, and assessing risk. The company was incorporated in 2012 and is based in Cambridge, Massachusetts.